Cryoablation+Ipilimumab+Nivolumab in Melanoma
Clinical trial NCT05779423 · RECRUITING
Trial details
- NCT number
- NCT05779423
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-23
- Primary completion
- 2028-01-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.